Abstract
Aminopropyltransferases are essential enzymes that form polyamines in eukaryotic and most prokaryotic cells. Spermidine synthase (SpdS) is one of the most well‐studied enzymes in this biosynthetic pathway. The enzyme uses decarboxylated S‐adenosylmethionine and a short‐chain polyamine (putrescine) to make a medium‐chain polyamine (spermidine) and 5′‐deoxy‐5′‐methylthioadenosine as a byproduct. Here, we report a new spermidine synthase inhibitor, decarboxylated S‐adenosylhomocysteine (dcSAH). The inhibitor was synthesized, and dose‐dependent inhibition of human, Thermatoga maritima, and Plasmodium falciparum spermidine synthases, as well as functionally homologous human spermine synthase, was determined. The human SpdS/dcSAH complex structure was determined by X‐ray crystallography at 2.0 Å resolution and showed consistent active site positioning and coordination with previously known structures. Isothermal calorimetry binding assays confirmed inhibitor binding to human SpdS with K~d~ of 1.1 ± 0.3 μ__M__ in the absence of putrescine and 3.2 ± 0.1 μ__M__ in the presence of putrescine. These results indicate a potential for further inhibitor development based on the dcSAH scaffold.